Company profile
AEON Biopharma, Inc.
AMEX:AEONBiotechnology: Pharmaceutical Preparations
Clinical trials (4)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT04849988 | phase2 | completed | 2021-03-29 | 2022-07-11 | AEON Biopharma, Inc. | A Phase 2 Study to Evaluate the Safety and Efficacy of ABP-450 in the Treatment of Cervical Dystonia |
| NCT04871451 | phase2 | completed | 2021-07-27 | 2023-07-24 | AEON Biopharma, Inc. | Extension Study of ABP-19000 to Evaluate Safety and Efficacy of Repeat Treatments of ABP-450 in Cervical Dystonia |
| NCT05016661 | phase2 | terminated | 2021-10-19 | 2024-07-31 | AEON Biopharma, Inc. | Extension Study of ABP-20001 to Evaluate Safety and Efficacy of Repeat Treatments of ABP-450 for Migraine Prevention |
| NCT04845178 | phase2 | completed | 2021-03-01 | 2024-06-19 | AEON Biopharma, Inc. | Investigation of Safety and Efficacy of ABP-450 for Migraine Prevention in Adults |
FDA applications (0)
No records yet.